The US FDA (Food and Drug Administration) has approved authorisation for “Byooviz” (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) “for the treatment of… Read More »FDA approval announces the first biosimilar in the USA for ranibizumab (Lucentis) intravitreal injection in neovascular AMD, RVO and myopic CNV
Researchers based at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London UK, have presented preliminary data results on X-linked retinitis pigmentosa (XLRP) at the… Read More »Phase 1/2 study of AAV5-RPGR gene therapy for RPGR-associated X-Linked Retinitis Pigmentosa present preliminary results
Researchers from King’s College London, UK have published a systematic review and meta-analysis on individual participant data from RCT literature using evidence on ocriplasmin’s effect… Read More »A systematic review and meta-analysis on individual participant data, within 5 RCTs, on the treatment of ocriplasmin for vitreomacular adhesion resolution.
Researchers led at the Karl Landsteiner Institute for Retinal Research and Imaging, Vienna, Austria, have reported that the discontinuation of treatment on exudative neovascular age… Read More »Treatment discontinuation of anti-VEGF administration during the COVID-19 pandemic has deteriorated visual acuity.
A clinical research team, based at the Federal University of São Paulo, Brazil, has reported that COVID-19 proteins have been identified within cells of the… Read More »SARS-CoV-2 virus particles were detected in the human retina in patients with COVID-19
An expert clinical research team, based at the University of Bonn, Germany, has reported a short-term real-world outcome study for intravitreal brolucizumab for neovascular AMD. … Read More »A University of Bonn report provides real-world outcome study on brolucizumab for neovascular AMD (nAMD)
An international consortium of researchers, led in the UK, with Japan, USA, India and Switzerland, have reported results of a systematic review on complications in… Read More »A systematic review using the CONSORT Extension for Harms framework has presented the reporting of complications in retinal detachment surgical trials.
Researchers led by clinical experts at the National Institute for Health Research, Moorfields Biomedical Research Centre, London, have reported results from a Healthy Technology Assessment… Read More »A formal Health Technology Assessment (HTA) reported key results on intravitreal treatments of ranibizumab, aflibercept and bevacizumab for macular oedema due to CRVO.
Researchers based at the Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, CNRS, Paris, have reported partial recovery of visual function… Read More »A clinical study with a combined novel optogenetic therapy and a light-stimulating device has highlighted partial recovery of visual function on an RP patient.
Researchers at King’s College London, UK have reported that 192,986 European participants, across 10 populations, have identified 124 independent associations arising from 61 discrete genomic… Read More »A clinical study on eye colour, using genome-wide association analysis, has identified 50 previously unidentified genetic loci